Estimation of Serum Uric acid, Creatinine, Total Cholesterol and LDL among Sudanese Using Atorvastatin Drug

Journal Title: Saudi Journal of Biomedical Research - Year 2018, Vol 3, Issue 2

Abstract

Abstract:Atorvastatin is lipid lowering drug use in different cases to prevent complications of hyperlipidemia by lowering lipid mainly affect cholesterol, but it also affect in concentration of other serum parameters such as uric acid and creatinine. Case-control study was conducted during the period between Marchs to May 2017, included 100 participants 60% cases and 40% control with age between (20-70) years. Case group included 62% female and 38% male, used different doses (10, 20 and 40 mg/day) and different durations using for variable conditions such as (DM, HTN or protection for risk of CVD). Control group was matched for cases group but not used any lipid lowering drugs. The result of this study showed that significant association between atorvastatin uses and decrease in UA, Cr, T.Chl and LDL (P-value: 0.000, 0.020, 0.015 & 0.018 respectively). Decrease in all parameters by increase dose but not significant only significant with dose 40 mg/day (p-value: 0.037, 0.044, 0.044 & 0.005 respectively). Decrease in Cr, TCh and LDL by increasing the durational of atorvastatin intake and concentration (P= 0.042, 0.001 & 0.000 respectively). Significant relation was detected between combination DM & HTN and increase UA (4.55±0.87) & Cr (0.69±0.16) (P-value: 0.032 & 0.015 respectively) no significant relation with T.Chl and LDL (P-value: 0.636 & 0.594 respectively). Significant decrease in UA, Cr, T .Cho & LDL mean concentration found among atorvastatin user and the dose 40mg/day is highly significant effect. No correlation between durational of atorvastatin used and the parameter concentration. A more research should be done to detect specific correlation between atorvastatin and this parameters. Keywords: Hyperlipidemia; Lipid lowering Drug (atorvastatin); Uric acid; Creatinine; Diabetes Mellitus (DM); Hypertension (HTN); Cardiovascular Disease (CVD).

Authors and Affiliations

Ahmed O. Abuelhassan, Abdelkarim A. Abdrabo, Abdelgadir Eltom

Keywords

Related Articles

Effectof Aqueous Root Extract of Cassia occidentalison Acetaminophen Induced Hepatorenal Toxicity Rat Model

Abstract: Indiscriminate usage of Cassia occidentalisin treating many diseases has been locally practiced, the need for ascertaining the epicacy of the extract in management of liver and kidney damage become imperative....

Identification and immune recognition of viral epitopes of West Nile Virus envelope glycoprotein and their potentials of acting as peptide vaccine

Abstract: West Nile virus (WNV) is a small, enveloped, mosquito transmitted virus with a positive sense, 11 kb RNA genome. It was first isolated in 1937 from a woman with an undiagnosed febrile illness in the West Nile d...

Bioremediation Potential of Zn (II) By Different Bacterial Species

Abstract:Heavy metals are generally toxic to microorganisms, especially if they exist at high concentrations. Environmental pollution particularly in soil with heavy metals can stem from industrial activities or sewage d...

The influence of seasonal variation on the serum progesterone of Black Bengal does (Capra aegagrushircus)

Abstract: The Black Bengal does of Indian sub-continent generally show a noted seasonal variation during in reproductive activity. India has a good quality of Black Bengal goat populations, which has significant role in...

Vitamin D Deficiency in PCOS Affected Sudanese Ladies with Infertility Disorders

Abstract:Vitamin D plays a role with hormones in their receptor sites. Without vitamin D, hormones cannot function the way they would normally. The receptor sites malfunction, leaving estrogen, progesterone, testosterone...

Download PDF file
  • EP ID EP397838
  • DOI -
  • Views 92
  • Downloads 0

How To Cite

Ahmed O. Abuelhassan, Abdelkarim A. Abdrabo, Abdelgadir Eltom (2018). Estimation of Serum Uric acid, Creatinine, Total Cholesterol and LDL among Sudanese Using Atorvastatin Drug. Saudi Journal of Biomedical Research, 3(2), 39-43. https://europub.co.uk/articles/-A-397838